Streetbeat News

Regulatory

SPY

The ISM Manufacturing PMI for July came in at 46.4, slightly below the expected 46.8 and above the prior figure of 46.0.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 8:21 am

SPY

The ISM Manufacturing Prices for July came in at 46.4, which is higher than the estimated 42.8 and the prior figure of 41.8.

Portfolio Pulse from Happy Mohamed

August 04, 2023 | 8:07 am

META

Meta Platforms Inc. (NASDAQ:META) has proposed to European Union regulators that it will ask users if they want to see targeted advertisements or not and accordingly tailor its data collection. This comes after Meta has faced regulatory scrutiny and fines over its data collection and privacy policies. The inability to deliver targeted ads in Europe could impact Meta's revenue, as advertisement revenue accounts for 97.5% of Meta’s total revenue in 2022, at $113.64 billion.

Portfolio Pulse from Rounak Jain

August 01, 2023 | 3:28 pm

BNBUSD

NMR

Nomura's digital asset subsidiary, Laser Digital, has secured an operating license from Dubai's Virtual Asset Regulatory Authority (VARA). The license allows Laser Digital to provide virtual asset broker-dealer services and virtual asset management and investment services. The company plans to start its trading and asset management operations in the coming months, offering over-the-counter trading services and a range of digital asset investment products.

Portfolio Pulse from Murtuza Merchant

August 01, 2023 | 3:12 pm

GSK

The FDA has approved GSK plc's Jemperli in combination with carboplatin and paclitaxel for primary advanced or recurrent endometrial cancer. The approval is supported by interim analysis results from a phase 3 trial, which demonstrated a significant benefit in patients treated with Jemperli. Despite the approval, GSK shares are down 1.04% at $35.20.

Portfolio Pulse from Vandana Singh

August 01, 2023 | 3:08 pm

MDNA

Medicenna Therapeutics Corp. has been granted U.S. Patent No. 11,680,090 for a method that enhances immune cell survival and proliferation, potentially improving the fitness of cancer-fighting immune cells.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2023 | 3:04 pm

WISH

ContextLogic, the parent company of Wish, plans to realize run-rate savings of approximately $43M-$46M annually starting in Q4 of 2023. This includes about 160 employees in the United States, representing about 41% of the company's domestic workforce, and about 95 non-U.S. employees, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2023 | 3:01 pm

WISH

ContextLogic Inc. has announced a plan to refocus its operations to support ongoing business prioritization efforts, better align resources, and improve operational efficiencies, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2023 | 3:00 pm

DBVT

DBV Technologies has received FDA support for its COMFORT Toddlers and COMFORT Children supplemental safety studies for peanut allergies. The studies will enroll children aged 1-7 years and aim to support the efficacy results from the EPITOPE and VITESSE Phase 3 pivotal studies. The company reported Q2 sales of $2.28 million, up from $1.53 million a year ago, and an EPS loss of $(0.26), down from $(0.35) a year ago. DBVT shares are up 8.11% at $1.60 during the premarket session.

Portfolio Pulse from Vandana Singh

August 01, 2023 | 2:59 pm

WISH

Trading of ContextLogic shares has been halted due to pending news.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2023 | 2:54 pm